Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mitzner

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Gene Therapy|September 25, 1998
Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cellsM Pelegrin, M Marin, D Noël, et al.
Gene Therapy|May 18, 1999
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450M Löhr, P Müller, P Karle, et al.
Journal of Microencapsulation|June 29, 2001
In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transferS Armeanu, I Haessler, R Saller, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Drugs in liver disease and during albumin dialysis -MARSJ Majcher-Peszynska, P Peszynski, S C Müller, et al.
Infection|January 8, 2013
Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrheaH F Geerdes-Fenge, M Löbermann, M Nürnberg, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Gene Therapy|September 25, 1998
Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cellsM Pelegrin, M Marin, D Noël, et al.
Gene Therapy|May 18, 1999
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450M Löhr, P Müller, P Karle, et al.
Journal of Microencapsulation|June 29, 2001
In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transferS Armeanu, I Haessler, R Saller, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Drugs in liver disease and during albumin dialysis -MARSJ Majcher-Peszynska, P Peszynski, S C Müller, et al.
Infection|January 8, 2013
Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrheaH F Geerdes-Fenge, M Löbermann, M Nürnberg, et al.
Pageof 3